cupure logo
dealtariffstrumppricepricestradecuttescoworkersyear

Wes Streeting’s row with pharma firms grows as talks end on NHS drug pricing

Drugmakers reject health secretary’s latest offer, meaning ‘unsustainable’ rebate scheme will stay in placeBusiness live – latest updatesA row between Wes Streeting and pharmaceutical companies has intensified after drugmakers rejected the health secretary’s latest offer on NHS drug pricing.Talks broke up without agreement on Friday, meaning the mechanism under which the health service claws back some of the money it pays for medicines will continue at a rate the industry has called “unsustainable” and says could discourage companies from making investments in the UK. Continue reading...

Comments

Business News